FDA Announces Final Guidance for Proprietary Names of New Animal Drugs

Summary

The Food and Drug Administration (FDA) has released a final guidance document to help new animal drug manufacturers choose proprietary names that do not cause medication errors or misbrand the drug, and explains how to request evaluation of proposed names by the Center for Veterinary Medicine (CVM)